Healthcare Sales & Marketing Network: Market Research Marketplace

The Healthcare Sales & Marketing Network(R): Sales & Marketing News, Information and Networking for Medical Devices, Pharmaceuticals and Biotechnology.

Healthcare Sales & Marketing Network celebrates eleven years serving the medical device, biopharmaceutical and diagnostics community!

Market Research

POSITIONS AVAILABLE
—New Jobs: JUN 5

HOSPITALS - USA

MEMBERS:

MOBILE NEWS New!

NewsTRACKER

NewsARCHIVE

BREAKING NEWS:

Alcon

Nephros

sanofi-aventis

Neuromed Pharmaceuticals

King Pharmaceuticals

RaySearch Laboratories

Applied Spine Technologies

Shire plc

Eisai

Morphotek

Myriad Pharmaceuticals

Laboratory Corporation of America

ArthroCare

Acorda Therapeutics

Teva Pharmaceutical

MMDI

AMAG Pharmaceuticals

Small Bone Innovations

Hospira

Edwards Lifesciences

Catalyst Biosciences

W. L. Gore

Hyperion Therapeutics

Cell Genesys

Tryton Medical

DOR BioPharma

Horizon Therapeutics

Teva Pharmaceutical

Watson Pharmaceuticals

Wake Pharm US

more...

Market Research Marketplace: Authoritative, up-to-the-minute Reports and Industry Analysis from leading Market Research firms

Category:		Reports Available (click for synopsis):
Special price offers!		Anti-Counterfeiting Strategies - Combating Fake Pharmaceuticals ‑ 10% discount! Big Pharma M&A Analysis to 2012 - Surveying the growth rate landscape ‑ 15% discount! Commercial Insight: Asthma & COPD - Combination products still have blockbuster potential ‑ 20% discount! Commercial Insight: Autoimmune Overview - Market continues to prosper ‑ 10% discount! Commercial Insight: HIV - Reshaping Treatment Paradigms ‑ 20% discount! Commercial Insight: Targeted Therapy Cancer Brands - High growth market will see eight new blockbusters by 2017 ‑ 15% discount! Commercial Insight: Top 20 Cancer Therapy Brands - Sales of targeted therapies overtake cytotoxics in 2006 ‑ 20% discount! Disease Management and Drug Adherence: Strategies to support patients and enhance treatment persistence ‑ 20% discount! eHealthInsight Series: The Changing Direct-to-Consumer Advertising Landscape ‑ 15% discount! Generic Series: Benchmarking Patent Expiries - Key Factors Affecting Brand Erosion at Patent Expiry ‑ 20% discount! Generic Series: Optimizing Brand Lifecycle Management Winning Strategies to Maximize Revenue in the Face of Growing Generic Competition ‑ 15% discount! Generics Series: Generics Trends in the Seven Major Markets and Beyond ‑ 15% discount! Patient Empowerment: empowered patients can change healthcare outcomes and impact the pharmaceutical industry ‑ 20% discount! Pharmaceutical Branding Strategies: Thought leader perspectives on brand building, effective communication and future brand models ‑ 30% discount! Pharmaceutical Licensing Strategies: Best practices in deal-making, valuations and strategic management ‑ 30% discount! Pharmaceutical Outsourcing Strategies: Market expansion, offshoring and strategic management in the CRO and CMO marketplace ‑ 30% discount! Pharmaceutical Strategic Alliances: Maximizing returns from collaborative development and commercialization ‑ 25% discount! Pipeline Insight: Antithrombotics - Reaching the untreated prophylaxis market ‑ 20% discount! Sales Force Effectiveness ‑ 15% discount! Stakeholder Opinions: Vaccine adjuvants - uncertainties rule ‑ 15% discount! The Pharmaceutical Company Outlook to 2012: Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech ‑ 10% discount! The Pharmaceutical Industry: Key trends and strategic issues shaping the industry. ‑ 25% discount! The Promotional Landscape in US and Europe: Benchmarking promotional ROI and optimizing detailing and journal spend ‑ 15% discount! The Top 10 Generic Pharmaceutical Companies: Positioning, performance and SWOT analyses ‑ 15% discount! Winning Pharmaceutical Brand Management: Maximizing brand value through best practice in brand development and product marketing ‑ 30% discount!

Editor's Choice Reports		Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape Biotechnology: Global Industry Guide Commercial Insight: Community Antibacterials - Pipelines wither as generic tidal wave takes its toll Commercial Insight: Rheumatoid arthritis - Anti-TNFs defend first-line biologic position despite competition Commercial Insight: Solid organ transplantation - The impact of new biologics, generics and reformulations Divestment Strategies: Pharma is divesting in order to grow Forecast Insight: Antithrombotics - Market growth dependent on new agents Forecast Insight: Depression - Generic induced brand erosion leads to market decline Forecast Insight: Epilepsy - Future market upgrade following new drug launches Forecast Insight: Migraine - Generic incursion inhibits market growth Generics: Global Industry Guide Infectious Diseases Vaccine Market Overview: Key Companies & Strategies - In times of crisis, Big Pharma turns to vaccines Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment Molecular Diagnostics: a primer on an emerging sector Orthopedics: Global Industry Guide Pharmaceutical Company Outlook to 2013 Pipeline and Commercial Insight: Anxiety Disorders - Viable indication for antipsychotics companies Pipeline and Commercial Insight: Hepatitis C - High unmet need drives rapid innovation Pipeline Insight: Cancer Overview - Gastrointestinal, Skin, Sarcomas Pipeline Insight: Molecular Targeted Cancer Therapies - More pipeline activity, less product differentiation Pipeline Insight: Orphan Diseases in Neurology - Part III: Myasthenia Gravis Stakeholder Insight: Acute Coronary Syndromes ACS in Europe, what is the best practice? Stakeholder Insight: Chronic Leukemias - Is there room left for improvement? Stakeholder Insight: Infertility - Undifferentiated drugs force need to strengthen prescriber and payer relationship Stakeholder Insight: Spondyloarthropathies - Disease perception limits market potential Stakeholder Insight: Systemic Lupus Erythematosus Imprecise segmentation complicates treatment algorithms Stakeholder Opinions: Bladder Cancer - New drugs needed to challenge ineffective 20-year old drugs Stakeholder Opinions: Diabetic Renal Disease Stakeholder Opinions: Narcolepsy - Entry-point to a lucrative fatigue-associated market Stakeholder Opinions: Restless Legs Syndrome - Novel drugs to prosper as lifecycle management strategies fail Stakeholder Opinions: Sarcomas Stakeholder Opinions: Type 2 Diabetes in the UAE & Saudi Arabia Growth opportunities in fragmented markets The Cancer Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities The Pharmaceutical Market Outlook to 2018: Key threats and opportunities for Big Pharma and its responses to them The Top Ten Specialty Pharmaceutical Companies: Positioning, performance and SWOT analyses

Allergy & Respiratory		Advanced Life Sciences' Cethromycin - Phase III success should allow 'me-too' market entry and above-consensus growth Commercial and Pipeline Insight: Allergic Rhinitis Commercial Insight: Asthma/COPD - ICS/LABA combinations continue to dominate Forecast Insight: Asthma/COPD - Little long-term future for long-acting single-agent inhalers? Forecast Insight: Asthma/COPD - Little long-term future for long-acting single-agent inhalers? Immunotherapy in Allergic Rhinitis - Moving away from injections Innovations and Pipelines for Respiratory Disorders: Niche markets, new products and future developments Stakeholder Insight: Asthma - Over-prescribing is common in intermittent and mild forms of asthma Stakeholder Opinions: Asthma Phenotypes A changing paradigm Stakeholder Opinions: Portable Inhaler Devices - Key tools to differentiate brands and survive generic pressure Stakeholder Opinions: Respiratory Syncytial Virus (RSV) - A market yet to reach its full potential The Asthma, COPD & Allergic Rhinitis Market Outlook to 2011

Anesthesia		Anesthesia Drugs: Worldwide Markets

Antibiotics		Anti Infectives, Vol II: Antibacterials Anti-Infectives: World Market, 2nd. Ed., Vol. I: Antifungals Commercial & Pipeline Insight: Hospital Antibacterials A market beyond MRSA Commercial Insight: Antibacterials - Growth in resistance rates drives niche indications Stakeholder Insight: Respiratory Tract Infections in the USA - The demise of narrow-spectrum antibiotics The Anti-Infectives Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities The Anti-Infectives Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities The Global Anti-Infectives Market Outlook to 2011

Antithrombotics		Commercial Insight: Antithrombotics - Market expands as disease management focuses on prevention

Antivirals		Commercial Insight: Select herpes viruses and human papilloma virus - Non-biologic interventions for oral and genital herpes, cytomegalovirus infection, herpes zoster and genital warts

Arthritis		Commercial Insight: Osteoarthritis - Market sees steady growth Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses Pipeline Insight: Disease Modification in Rheumatoid Arthritis - Competition for the anti-TNF failure patient population increases Stakeholder Insight: Rheumatoid Arthritis - Biologics battle up the treatment algorithm Stakeholder Opinions: Osteoarthritis - Preconceptions Damage Awareness and Treatments Worldwide Market for Rheumatoid Arthritis and Lupus Treatments (Autoimmune Disease Markets)

Autoimmune		Autoimmune Market Outlook to 2012 Immunomodulators: Therapeutic Needs, Pipelines & Prospects

Biosimilars		Biosimilars Series: Regulatory and development issues hurdles exist but are surmountable Biosimilars Series: Stakeholder Analysis Biosimilars Series: Strategic issues - Potential remains uncertain Biosimilars: Benchmarking the key players - With increasing regulatory clarity and high revenue potential, interest in biosimilars increases

Cardiology		Commercial Insight: Antidyslipidemics - Branded statins beware, generics are amongst you Commercial Insight: Antidyslipidemics - The competitive cost-conscious antidyslipidemics market presents challenges Commercial Insight: Antihypertensives - New challenges for a maturing market Commercial Insight: Antithrombotics - Pipeline products to dampen the impact of patent expiries and cost containment initiatives Commercial Insight: Cardiovascular market overview - Raft of patent expires threaten blockbusters Congestive Heart Failure: Major World Markets, Volume I: Pharmaceutical Management Congestive Heart Failure: Major World Markets, Volume II: Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets) Forecast Insight: Antihypertensives Key patent expiries prevent market growth Forecast Insight: Dyslipidemia - Genericization and negative trial data drive market shrinking Heart Health Food and Drinks: NPD in cardiovascular health, hypertension and cholesterol reduction Innovations in Cardiovascular Disease Management: Latest surgical procedures, drugs and medical devices Major World Markets for Stents and The Economics of Drug-Eluting Technology Pipeline Insight: Heart failure Weak pipeline dominated by new indications and add-on diuretics Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries Stakeholder Insight: Acute Coronary Syndromes Fresh look at ACS in Europe, what is the real picture? Stakeholder Insight: Atherosclerosis - HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities for future treatment Stakeholder Insight: Atrial Fibrillation - Limited efficacy and poor safety lead to bleak outlook Stakeholder Opinions: Heart Failure - When drugs do not work The Asian Cardiovascular Market Outlook to 2010 The Cardiovascular Disorders Market Outlook to 2012 The Cardiovascular Market Outlook to 2011 The Eastern European Cardiovascular Market Outlook to 2010 The Latin American Cardiovascular Market Outlook to 2010 World Cardiovascular Drug Market (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents)

Clinical Trials		Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets Offshoring Clinical Trials (The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel.) Online patient recruitment and its impact on patient relationship management Trends in Clinical Trials: Strategies to enhance clinical trial design

Company Profiles		Abbott Laboratories: PharmaVitae Profile Acambis PLC: Premium Company Profile Achillion Pharmaceuticals: Company Profile Acorda Therapeutics: Premium Company Profile Actelion Ltd: PharmaVitae Profile Akzo Nobel/Organon: PharmaVitae Profile Alcon Inc.: PharmaVitae Profile Alexion Pharmaceuticals: Company Profile Alexza Pharmaceuticals: Company Profile Allergan: PharmaVitae Profile Allos Therapeutics: Premium Company Profile Almirall: PharmaVitae Profile Alpharma: Premium Company Profile Altana: PharmaVitae Profile Altus Pharmaceuticals: Company Profile Amgen Inc.: PharmaVitae Profile Amylin Pharmaceuticals: Premium Company Profile Anesiva Inc: Premium Company Profile Antares Pharma: Premium Company Profile Antisoma plc: Premium Company Profile ArQule Inc: Premium Company Profile Aspreva Pharmaceuticals Corporation: Premium Company Profile Astellas: PharmaVitae Profile AstraZeneca plc: PharmaVitae Profile Auxilium Pharmaceuticals: Premium Company Profile Avigen Inc: Premium Company Profile Barr Pharmaceuticals Inc.: PharmaVitae Profile Barrier Therapeutics: Premium Company Profile Bayer Schering Pharma AG: PharmaVitae Profile Beckman Coulter Inc: Premium Company Profile Becton, Dickinson and Co: Premium Company Profile Biogen Idec: PharmaVitae Profiles BioMarin Pharmaceutical: Premium Company Profile